Never report 33275 in conjunction with code 33274. If you report pacemakers and implantable defibrillators in your cardiology practice, make sure you study the new rules and codes in the 2019 CPT® manual. Although there is a lot of new information to keep track of, you don’t have to fall behind. Read on to help keep your pacemaker claims in tip-top shape. Focus on 33274, 33275 Rules This year, you’ll find two new codes in the pacemaker/implantable defibrillator section of the CPT® manual. They are as follows: Along with these codes come the following new CPT® guidelines you must adhere to: Leadless cardiac pacemaker system defined: A leadless cardiac pacemaker system includes “a pulse generator with built-in battery and electrode for implantation in a cardiac chamber via a transcatheter approach,” according to the CPT® manual. Tackle These Transvenous Electrode Removal Guidelines The new CPT® guidelines also clarify how you should handle situations where the cardiologist removes transvenous electrodes. The cardiologist may first attempt to remove the transvenous electrodes via transvenous extraction — codes 33234 (Removal of transvenous pacemaker electrode(s); single lead system, atrial or ventricular); 33235 (Removal of transvenous pacemaker electrode(s); dual lead system); or 33244 (Removal of single or dual chamber implantable defibrillator electrode(s); by transvenous extraction). In cases where this transvenous extraction is unsuccessful, the cardiologist may then perform a thoracotomy (codes 33238 (Removal of permanent transvenous electrode(s) by thoracotomy) or 33243 (Removal of single or dual chamber implantable defibrillator electrode(s); by thoracotomy)) to remove the electrodes. If appropriate, you should submit insertion codes 33212, 33213, 33221, 33230, 33231, 33240 in addition to thoracotomy or endoscopic epicardial lead placement codes (33202 or 33203) to report the generator insertion, if the same physician performs the service during the same session. Additionally, you can separately report the removal of a subcutaneous implantable defibrillator electrode with code 33272 (Removal of subcutaneous implantable defibrillator electrode). If you need to report the removal and replacement of a leadless pacemaker system during the same session, submit code 33274. And, if you are reporting the removal of a leadless pacemaker system without replacement, submit 33275. Observe New Device Evaluation Clarification The CPT® guidelines also explain how to appropriately report the following device evaluation codes: Don’t miss: You cannot report codes 93260, 93261, or 93279-93299 in conjunction with pulse generator and lead insertion or revision codes 33206-33249; 33262-33264; or 33270-33273. Additionally, you cannot report device evaluation codes 93279, 93286, 93288, 93294, or 93296 in conjunction with leadless pacemaker insertion and removal codes 33274 or 33275. Hone in on 3 Rules for Reporting DFT Check out what the new CPT® guidelines have to say about defibrillator threshold testing (DFT). Rule 1: You can separately report DFT during transvenous implantable defibrillator insertion (33249) or replacement (33262-33264) with codes 93640 (Electrophysiologic evaluation of single or dual chamber pacing cardioverter-defibrillator leads including defibrillation threshold evaluation (induction of arrhythmia, evaluation of sensing and pacing for arrhythmia termination) at time of initial implantation or replacement) or 93641 (… with testing of single or dual chamber pacing cardioverter-defibrillator pulse generator), Neighbors explains. Rule 2: It is not appropriate to separately report DFT testing during subcutaneous implantable defibrillator system insertion (33270). Rule 3: You can separately report DFT testing for transvenous or subcutaneous implantable defibrillator in follow-up (DFT test not at time of implant) or at the time of replacement with codes 93642 (Electrophysiologic evaluation of single or dual chamber transvenous pacing cardioverter-defibrillator (includes defibrillation threshold evaluation, induction of arrhythmia, evaluation of sensing and pacing for arrhythmia termination, and programming or reprogramming of sensing or therapeutic parameters)) or 93644 (Electrophysiologic evaluation of subcutaneous implantable defibrillator (includes defibrillation threshold evaluation, induction of arrhythmia, evaluation of sensing for arrhythmia termination, and programming or reprogramming of sensing or therapeutic parameters)).